Expression of Erythropoietin in the Spinal Cord of Lewis Rats with Experimental Autoimmune Encephalomyelitis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and PurposeaaErythropoietin (Epo), originally recognized for its central role in erythropoiesis, has been shown to improve the outcomes in patients with various neurological disorders. The aim of this study was to elucidate the Epo expression pattern in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis (EAE) and to assess the systemic effect of Epo during the course of EAE. MethodsaaWe used an EAE model induced in Lewis rats by immunization with myelin basic protein. Immunized rats were given recombinant human Epo (rhEpo) intraperitoneally at a dose of 5,000 U/kg for 7 consecutive days, either starting on day 3 post-immunization (five rats) or on the day of clinical symptom onset (score ≥1, five rats). After immunization, the rats were observed daily for clinical signs of EAE. Epo expression was investigated by Western blot analysis and immunohistochemistry. ResultsaaWestern blot analysis showed that, Epo expression was significantly elevated relative to control in the rat spinal cord during the peak stage of EAE (p<0.05), and then decreased thereafter. Immunohistochemistry demonstrated that Epo was expressed in some neurons and glial cells. Epo immunoreactivity was detected in ED1-positive macrophages and astrocytes in EAE lesions. Furthermore, we found that the intraperitoneal administration of rhEpo reduced both the disease severity and duration of paralysis in EAE rats, and reduced macrophage activity and increased Epo activity. ConclusionsaaBased on these findings, we postulate that Epo expression begins to increase at the start of EAE and that rhEpo administration leads to functional recovery from EAE paralysis.
Abstract
Background and PurposeaaErythropoietin (Epo), originally recognized for its central role in erythropoiesis, has been shown to improve the outcomes in patients with various neurological disorders. The aim of this study was to elucidate the Epo expression pattern in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis (EAE) and to assess the systemic effect of Epo during the course of EAE. MethodsaaWe used an EAE model induced in Lewis rats by immunization with myelin basic protein. Immunized rats were given recombinant human Epo (rhEpo) intraperitoneally at a dose of 5,000 U/kg for 7 consecutive days, either starting on day 3 post-immunization (five rats) or on the day of clinical symptom onset (score ≥1, five rats). After immunization, the rats were observed daily for clinical signs of EAE. Epo expression was investigated by Western blot analysis and immunohistochemistry. ResultsaaWestern blot analysis showed that, Epo expression was significantly elevated relative to control in the rat spinal cord during the peak stage of EAE (p<0.05), and then decreased thereafter. Immunohistochemistry demonstrated that Epo was expressed in some neurons and glial cells. Epo immunoreactivity was detected in ED1-positive macrophages and astrocytes in EAE lesions. Furthermore, we found that the intraperitoneal administration of rhEpo reduced both the disease severity and duration of paralysis in EAE rats, and reduced macrophage activity and increased Epo activity. ConclusionsaaBased on these findings, we postulate that Epo expression begins to increase at the start of EAE and that rhEpo administration leads to functional recovery from EAE paralysis.
참고문헌 (21)
- Sirén AL, "Erythropoietin--a novel concept for neuroprotection", Eur Arch Psychiatry Clin Neurosci, 251, pp.179~184 (2001)
- Buemi M, "The pleiotropic effects of erythropoietin in the central nervous system", J Neuropathol Exp Neurol, 62, pp.228~236 (2003)
- Brines M, "Emerging biological roles for erythropoietin in the nervous system", Nat Rev Neurosci, 6, pp.484~494 (2005)
- Marti HH, "Erythropoietin and the hypoxic brain", J Exp Biol, 207, pp.3233~3242 (2004)
- Shingo T, "Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells", J Neurosci, 21, pp.9733~9743 (2001)
- Yu X, "Erythropoietin receptor signaling is required for normal brain development", Development, 129, pp.505~516 (2002)
- Brines ML, "Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury", Proc Natl Acad Sci U S A, 통권 : 97, pp.10526~10531 (2000)
- Chung YH, "Agerelated changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats", Brain Res, 1018, pp.141~146 (2004)
- Wang L, "Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats", Stroke, 35, pp.1732~1737 (2004)
- Chung YH, "Enhanced expression of erythropoietin in the central nervous system of SOD1 (G93A) transgenic mice", Brain Res, 1016, pp.272~280 (2004)
- Agnello D, "Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis", Brain Res, 952, pp.128~134 (2002)
- Zhang J, "Erythropoietin treatment improves neurological functional recovery in EAE mice", Brain Res, 1034, pp.34~39 (2005)
- Li W, "Beneficial effect of erythropoietin on experimental allergic encephalomyelitis", Ann Neurol, 56, pp.767~777 (2004)
- Savino C, "Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis", J Neuroimmunol, 172, pp.27~37 (2006)
- Ruscher K, "Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model", J Neurosci, 22, pp.10291~10301 (2002)
- Sirén AL, "Erythropoietin and erythropoietin receptor in human ischemic", hypoxic brain, 2001, pp.101, 271~276
- Rotshenker S, "Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3", MAC-1)-mediated myelin phagocytosis in injury and disease, 2003, pp.21, 65~72
- Hammarberg H, "Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNSinfiltrating T and natural killer cells", J Neurosci, 20, pp.5283~5291 (2000)
- Trzonkowski P, "Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients", Nephrol Dial Transplant, 20, pp.367~376 (2005)
- Shin T, "The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis", J Neuroimmunol, 56, pp.171~178 (1995)
- Moon C, "Increased expression of p53 and Bax in the spinal cords of rats with experimental autoimmune encephalomyelitis", Neurosci Lett, 289, pp.41~44 (2000)